Global Leprosy Treatment Market is estimated to be US$ 4.09 billion by 2030 with a CAGR of 4.50%

COVINA, S.C. - Feb. 24, 2022 - PRLog -- lobal leprosy treatment market accounted for US$ 2.65 billion in 2020 and is estimated to be US$ 4.09 billion by 2030 and is anticipated to register a CAGR of 4.50%. Leprosy caused by a Mycobacterium leprae bacteria. Leprosy is principally a granulomatous disease & it affects the skin, upper respiratory tract mucosal surfaces, peripheral nerves and the eyes majorly. The symptoms of leprosy include reddish skin lesions, loss of sensation, and weakness of hands and muscles. It is likely to cause nerve damage so as to induce muscle numbness. It is a communicable disease that can propagated through contact with cough or phlegm of the affected person. Generally, it is prevalent in low-income countries & malnutrition as well as weak immune system are other significant risk factors of leprosy. Leprosy can be cured by the Multidrug Therapy (MDT) which includes mixture of drugs like rifampicin, clofazimine and dapsone.

Key Highlights:

• The United States Food and Medicine Administration has approved Novartis International AG's 'Egaten,' a drug used to treat fascioliasis and tropical diseases such as leprosy.
• The Novartis Foundation, a non-profit organisation that is part of Novartis International AG, partnered with Microsoft in March 2019 to develop an artificial intelligence (AI)-enabled digital health application and a leprosy intelligent image atlas to help with early leprosy detection.

To know the upcoming trends and insights prevalent in this market, click the link below:

https://www.prophecymarketinsights.com/market_insight/Global-Leprosy-Treatment-Market-4855 (https://www.prophecymarketinsights.com/PressRelease/Globa...)

Competitive Landscape & their strategies of Global Leprosy Treatment Market:

The key players operating in the leprosy treatment market includes the prominent player operating in the leprosy treatment market includes GlaxoSmithKline plc, Macleods Pharmaceuticals, Cadila Pharmaceuticals, Novartis AG, Systopic Laboratories Pvt. Ltd., AstraZeneca plc, Zydus Cadila, Merck & Co., Inc., Sanofi & HDT Biotech Corporation.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

To know more

Contact Us:

Sales

Prophecy Market Insights

1 860 531 2701 (http://tel)

Email- sales@prophecymarketinsights.com

Website- www.prophecymarketinsights.com